Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadruple Therapy (Zinc, Quercetin, Bromelain, Vitamin C) for COVID-19
NCT04468139Phase 4Unknown
- Sponsor
- Ministry of Health
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Modality
- Allosteric Modulators, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of quercetin, bromelain, zinc, ascorbic acid in coronavirus disease 2019 (COVID-19), sponsored by Ministry of Health. Status: unknown.
02
Drugs
quercetinbromelainzincascorbic acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04468139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04468139.